The Role of HuR in HIV related COPD
HuR 在 HIV 相关 COPD 中的作用
基本信息
- 批准号:10548660
- 负责人:
- 金额:$ 76.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Air MovementsAirway DiseaseAntigensAntioxidantsBindingBiological AssayBiologyCell Differentiation processCell ProliferationCellsCellular biologyChronicChronic Obstructive Pulmonary DiseaseCiliaCodeCohort AnalysisComplexComputer softwareCysteineCytosolDataDevelopmentDiseaseDisease modelEpithelial CellsEquilibriumFemaleFunctional disorderGene ExpressionGene Expression ProfileGenesHIVHIV Envelope Protein gp120HIV InfectionsHIV tat ProteinHumanImageImpairmentIn VitroIndividualInhalationInjuryInterventionKnock-outKnockout MiceLeftLongevityLongitudinal cohortLungMeasuresMediatingMediator of activation proteinMessenger RNAMicroRNAsModelingMolecularMorbidity - disease rateMusOutcomePathway interactionsPersonsPharmacologyPhysiologicalPrincipal InvestigatorProductionProteinsProto-OncogenesPublic HealthRNARNA-Binding ProteinsRetrospective cohortRisk FactorsRoleSRC geneSmokeStainsStructure of parenchyma of lungTestingTracheaTranslationsViraladeno-associated viral vectorairway epitheliumairway obstructionairway remodelingcell typecigarette smokecigarette smoke-induced COPDcohortdrinking waterearly onsetepithelial injuryepithelial repairexposure to cigarette smokehuman diseaseimprovedin vivoinjured airwayknock-downlocus ceruleus structuremRNA DecaymRNA Exportmalemortalitymouse modelnef Proteinnoveloxidative damagepatient populationprematurepreventprogramsprotein-tyrosine kinase c-srcpulmonary functionrepairedresponsesingle cell sequencingtraffickingtranscriptometranscriptome sequencingtranscriptomics
项目摘要
Summary: Both retrospective and longitudinal cohort analyses strongly associate HIV infection with the
premature initiation and progression of chronic obstructive pulmonary disease (COPD). Improving long-term
pulmonary outcomes and longevity in people living with HIV (PLWH) will require a better understanding of how
cigarette smoke accelerates COPD in this patient population. We know that exposure to cigarette smoke causes
proliferative and oxidative responses in airway epithelial cells that promote HIV-related COPD. Our prior studies
showed that the HIV protein Tat and chronic smoke exposure both reduced lung levels of the RNA binding
protein human antigen R (HuR), which regulates the balance between decay and translation of multiple mRNA
targets. Similarly, we determined that prolonged smoke exposure reduces HuR levels in primary human airway
epithelial cells (HAECs) isolated from COPD subjects and in lung tissue sections from COPD airways. The loss
of HuR is important since we found that chronic smoke exposure worsened airflow obstruction in airway specific
HuR knockout mice. Moreover, our RNA-seq studies discovered that knocking down HuR in HAECs dysregulates
cell proliferation and reduces antioxidant gene expression. Another line of evidence indicates that the proto-
oncogene tyrosine-protein kinase c-Src negatively regulates HuR expression. We identified enhanced c-Src
activation in HAECs from COPD subjects and in the lungs of EcoHIV infected mice. Thus, we hypothesize that
chronic smoke exposure and HIV induce c-Src to down regulate HuR and thereby impair airway epithelial repair
mechanisms in COPD. This loss of HuR alters the airway transcriptome to promote airflow obstruction in PLWH.
We will test the hypothesis in three aims:
Aim 1: We will use transcriptomic analysis to determine how HIV and cigarette smoke induce COPD by
altering gene expression in human airway epithelial cells from healthy, COPD and HIV/COPD subjects
Aim 2. We will employ in vivo HIV COPD models to ascertain how HuR in the airway epithelium counters
the oxidative damage that promotes airway injury and airflow obstruction in HIV.
Aim 3. We will employ in vitro and in vivo HIV COPD models to determine how c-Src regulates HuR to
alter oxidative and proliferative responses that promote airway injury and airflow obstruction in HIV.
These studies will set the stage for novel pharmacologic interventions that restore HuR expression to counter
the airway epithelial injury that impairs lung function and tissue integrity in HIV infected COPD subjects.
摘要:回顾和纵向队列分析都强烈地将艾滋病毒感染与
慢性阻塞性肺疾病(COPD)的过早发病和进展。改善长期发展
艾滋病病毒携带者(PLWH)的肺部结局和寿命需要更好地了解
在这些患者中,香烟烟雾会加速COPD的发生。我们知道暴露在香烟烟雾中会导致
促进HIV相关COPD的呼吸道上皮细胞的增殖和氧化反应。我们之前的研究
结果表明,HIV蛋白TAT和长期吸烟都降低了肺内与RNA结合的水平
蛋白质人类抗原R(Hur),调节多种mRNA的衰变和翻译之间的平衡
目标。同样,我们确定长时间的烟雾暴露会降低人体主要呼吸道的HUR水平。
从COPD患者和COPD呼吸道的肺组织切片中分离出上皮细胞(HAEC)。损失
HUR是很重要的,因为我们发现慢性烟雾暴露会加重特定呼吸道的气流阻塞
HUR基因敲除小鼠。此外,我们的rna-seq研究发现,在hAECs中敲除hur会导致失调。
促进细胞增殖,减少抗氧化剂基因表达。另一条证据表明,原始人-
癌基因酪氨酸蛋白激酶c-Src负性调节Hur的表达。我们确定了增强的c-Src
COPD患者HAECs和EcoHIV感染小鼠肺内HAECs的激活。因此,我们假设
慢性吸烟暴露和HIV诱导c-Src下调HUR,从而损害呼吸道上皮修复
慢性阻塞性肺疾病的发病机制。这种Hur的丢失改变了呼吸道转录组,促进了PLWH的气流阻塞。
我们将从三个方面检验这一假设:
目标1:我们将使用转录分析来确定HIV和香烟烟雾是如何通过以下方式诱发COPD的
正常人、COPD和HIV/COPD患者呼吸道上皮细胞基因表达的改变
目的2.我们将使用体内HIV COPD模型来确定呼吸道上皮中的HUR是如何起作用的
在HIV中促进呼吸道损伤和气流阻塞的氧化损伤。
目的3.我们将使用体外和体内HIV COPD模型来确定c-Src如何调节HUR到
改变氧化和增殖反应,促进HIV患者的呼吸道损伤和气流阻塞。
这些研究将为恢复HUR表达的新型药物干预奠定基础
HIV感染的COPD患者中损害肺功能和组织完整性的呼吸道上皮损伤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert F Foronjy其他文献
Robert F Foronjy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert F Foronjy', 18)}}的其他基金
The Effects of PP2A on TNF Signaling and Smoke-Induced Lung Injury
PP2A 对 TNF 信号传导和烟雾引起的肺损伤的影响
- 批准号:
7985794 - 财政年份:2010
- 资助金额:
$ 76.33万 - 项目类别:
The Effects of PP2A on TNF Signaling and Smoke-Induced Lung Injury
PP2A 对 TNF 信号传导和烟雾引起的肺损伤的影响
- 批准号:
8470691 - 财政年份:2010
- 资助金额:
$ 76.33万 - 项目类别:
The Effects of PP2A on TNF Signaling and Smoke-Induced Lung Injury
PP2A 对 TNF 信号传导和烟雾引起的肺损伤的影响
- 批准号:
8277888 - 财政年份:2010
- 资助金额:
$ 76.33万 - 项目类别:
The Effects of PP2A on TNF Signaling and Smoke-Induced Lung Injury
PP2A 对 TNF 信号传导和烟雾引起的肺损伤的影响
- 批准号:
8676588 - 财政年份:2010
- 资助金额:
$ 76.33万 - 项目类别:
The Effects of PP2A on TNF Signaling and Smoke-Induced Lung Injury
PP2A 对 TNF 信号传导和烟雾引起的肺损伤的影响
- 批准号:
8412115 - 财政年份:2010
- 资助金额:
$ 76.33万 - 项目类别:
相似海外基金
EXposomic Profiling in Airway disease to uNravel Determinants of disease in Asthma (EXPAND-Asthma) Center
气道疾病暴露组分析以解开哮喘疾病的决定因素 (EXPAND-Asthma) 中心
- 批准号:
10744673 - 财政年份:2023
- 资助金额:
$ 76.33万 - 项目类别:
Bacteriophage as a predictive biomarker in chronic Pseudomonas airway disease
噬菌体作为慢性假单胞菌气道疾病的预测生物标志物
- 批准号:
10723956 - 财政年份:2023
- 资助金额:
$ 76.33万 - 项目类别:
Defining a gene expression signature of airway disease, COPD exacerbations, and response to treatment
定义气道疾病、COPD 恶化和治疗反应的基因表达特征
- 批准号:
10733573 - 财政年份:2023
- 资助金额:
$ 76.33万 - 项目类别:
Impact of Maternal Arsenic Exposure on Offspring's Epigenetic Reprogramming of Allergic Airway Disease
母亲砷暴露对后代过敏性气道疾病表观遗传重编程的影响
- 批准号:
10733607 - 财政年份:2023
- 资助金额:
$ 76.33万 - 项目类别:
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory
厌氧微生物群在囊性纤维化气道疾病轨迹中的作用
- 批准号:
10716654 - 财政年份:2023
- 资助金额:
$ 76.33万 - 项目类别:
Immune Mediators of IL-22 Signaling Alter Allergic Airway Disease
IL-22 信号的免疫介质改变过敏性气道疾病
- 批准号:
10853347 - 财政年份:2023
- 资助金额:
$ 76.33万 - 项目类别:
Microbial adaptation of Pseudomonas lipid A structure in CF airway disease progress
假单胞菌脂质 A 结构在 CF 气道疾病进展中的微生物适应
- 批准号:
10722599 - 财政年份:2023
- 资助金额:
$ 76.33万 - 项目类别:
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory
厌氧微生物群在囊性纤维化气道疾病轨迹中的作用
- 批准号:
10985906 - 财政年份:2023
- 资助金额:
$ 76.33万 - 项目类别:
Mentoring patient-oriented researchers in inflammatory airway disease
指导炎症性气道疾病领域以患者为中心的研究人员
- 批准号:
10657746 - 财政年份:2022
- 资助金额:
$ 76.33万 - 项目类别:














{{item.name}}会员




